
Panpride-Pm 1mg/500mg/15mg Tablet
Marketer
Globus Remedies Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Panpride-Pm 1mg/500mg/15mg Tablet
Metformin/Pioglitazone/Glimepiride tablets (1mg/500mg/15mg) combine medications to manage blood glucose. This regimen, used alongside diet and exercise, enhances glycemic control in adults with type 2 diabetes. It improves insulin efficiency, thus reducing blood sugar. Dosage and duration should strictly follow your physician's instructions. Take with food to prevent gastric distress. Missed doses should be taken promptly unless nearing the next scheduled dose; then, omit the missed dose and resume the usual schedule. Never double the dose. Overdosage can cause hypoglycemia (low blood sugar). Concomitant use with other antidiabetic medications, alcohol, or meal skipping may increase hypoglycemia risk; regular blood sugar monitoring is crucial. Common adverse effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals require medical consultation before use. Kidney function tests will be performed before initiating this therapy. Limit alcohol consumption, as it may heighten the likelihood of side effects.
Uses of Panpride-Pm 1mg/500mg/15mg Tablet
Managing type 2 diabetes
Major Benefits of Panpride-Pm 1mg/500mg/15mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Panpride-Pm 1mg/500mg/15mg Tablet should be administered with a meal.
Common Side effects of Panpride-Pm 1mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Panpride-Pm 1mg/500mg/15mg Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or dividing it. Panpride-Pm 1mg/500mg/15mg tablets should be administered with a meal.
How Panpride-Pm 1mg/500mg/15mg Tablet works:
Panpride-PM, a 1mg/500mg/15mg tablet, combines glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. This triple therapy improves blood sugar management when single or dual drug regimens prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Panpride-Pm 1mg/500mg/15mg tablets with alcohol is hazardous.
PregnancyCONSULT YOUR DOCTOR
The use of Panpride-Pm 1mg/500mg/15mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against possible risks prior to prescription. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
The use of Panpride-Pm 1mg/500mg/15mg tablets while breastfeeding is likely inadvisable. Available evidence from human studies indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Panpride-Pm 1mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Consult a physician before use. Panpride-Pm 1mg/500mg/15mg tablets are contraindicated in individuals with severe kidney disease. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Individuals with liver impairment should exercise caution when using Panpride-Pm 1mg/500mg/15mg tablets. Dosage modification may be necessary; a physician's consultation is advised. Panpride-Pm 1mg/500mg/15mg tablets are contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Panpride-Pm 1mg/500mg/15mg Tablet :
Should you forget a Panpride-Pm 1mg/500mg/15mg Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Panpride-Pm 1mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
